Company Filing History:
1 out of 1,744 
1 out of 5,089 
1 out of 109 
Years Active: 2020-2025
Title: Nathalie Di Clemente-Besse: Innovator in Reproductive Medicine
Introduction
Nathalie Di Clemente-Besse is a prominent inventor based in Paris, France. She has made significant contributions to the field of reproductive medicine, particularly through her innovative research and patented inventions. With a total of two patents, her work focuses on therapeutic targets in ovarian carcinoma and reproductive health.
Latest Patents
Nathalie's latest patents include "Anti-müllerian inhibiting substance antibodies and uses thereof" and "Anti-mullerian hormone (AMH) neutralizing antibodies and uses thereof." The first patent addresses the potential therapeutic targets in ovarian carcinoma, specifically the Müllerian Inhibiting Substance (MIS) type II receptor and the MIS/MISRII signaling pathway. Her research indicates that ALK2 and ALK3 are the main receptors involved in MIS signaling, with implications for cancer treatment. The second patent relates to the use of AMH neutralizing antibodies in the field of reproduction, showcasing her commitment to advancing medical science.
Career Highlights
Nathalie has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her career is marked by a dedication to research and innovation, contributing to the understanding of reproductive health and cancer therapies.
Collaborations
Nathalie has collaborated with notable colleagues, including Nathalie Josso and Richard Cate. These partnerships have further enriched her research and expanded the impact of her inventions.
Conclusion
Nathalie Di Clemente-Besse is a trailblazer in the field of reproductive medicine, with her patents paving the way for innovative therapeutic approaches. Her work exemplifies the intersection of research and practical application in medicine.